National Cancer Institute; Notice of Meetings, 57224 [2020-20297]

Download as PDF 57224 Federal Register / Vol. 85, No. 179 / Tuesday, September 15, 2020 / Notices Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Gregory S Shelness, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6156, Bethesda, MD 20892–7892, (301) 755–4335, greg.shelness@nih.gov. Name of Committee: Genes, Genomes, and Genetics Integrated Review Group; Genetic Variation and Evolution Study Section. Date: October 15–16, 2020. Time: 9:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Guoqin Yu, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 435–1276, guoqin.yu@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: September 10, 2020. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–20307 Filed 9–14–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Meetings jbell on DSKJLSW7X2PROD with NOTICES Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of meetings of the President’s Cancer Panel. The meetings will be held as virtual meetings and are open to the public. Individuals who plan to view the virtual meetings and need special assistance or other reasonable accommodations to view the meetings should notify the Contact Person listed below in advance of the meetings. The meetings can be accessed by clicking on the following link: https://nci.rev.vbrick.com/#/ webcasts/presidentscancerpanel. Name of Committee: President’s Cancer Panel. Date: October 26, 2020. Time: 1:00 p.m. to 5:00 p.m. Agenda: Improving Resilience and Equity in Cancer Screening: Lessons from COVID–19 and Beyond (Day 1—Lung Cancer). Place: National Cancer Institute, 31 Center Drive, Building 31, Room 11A48, Rockville, MD 20850 (Virtual Meeting). VerDate Sep<11>2014 16:57 Sep 14, 2020 Jkt 250001 Access to Meeting: https:// nci.rev.vbrick.com/#/webcasts/ presidentscancerpanel. Contact Person: Maureen R. Johnson, Ph.D., Executive Secretary, President’s Cancer Panel, Special Assistant to the Director, National Cancer Institute, NIH, 31 Center Drive, Room 11A48 MSC 2590, Bethesda, MD 20892, 240–781–3327, johnsonr@mail.nih.gov. Name of Committee: President’s Cancer Panel. Date: October 28, 2020. Time: 1:00 p.m. to 5:00 p.m. Agenda: Improving Resilience and Equity in Cancer Screening: Lessons from COVID–19 and Beyond (Day 2—Lung Cancer). Place: National Cancer Institute, 31 Center Drive, Building 31, Room 11A48, Bethesda, MD 20892 (Virtual Meeting). Access to Meeting: https:// nci.rev.vbrick.com/#/webcasts/ presidentscancerpanel. Contact Person: Maureen R. Johnson, Ph.D., Executive Secretary, President’s Cancer Panel, Special Assistant to the Director, National Cancer Institute, NIH, 31 Center Drive, Room 11A48 MSC 2590, Bethesda, MD 20892, 240–781–3327, johnsonr@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: http:// deainfo.nci.nih.gov/advisory/pcp/index.htm, where agendas and any additional information for the meetings will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: September 9, 2020. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–20297 Filed 9–14–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Eye Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Eye Institute Special Emphasis Panel; NEI Institutional Training Grant Applications. Date: October 21, 2020. Time: 10:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Eye Institute, National Institute of Health, 6700B Rockledge Drive, Suite 3400, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Jennifer C. Schiltz, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Activities, National Eye Institute, National Institutes of Health, 6700B Rockledge Drive, Suite 3400, Bethesda, MD 20817, 240–276–5864, jennifer.schiltz@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.867, Vision Research, National Institutes of Health, HHS) Dated: September 9, 2020. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–20286 Filed 9–14–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Mental Health Special Emphasis Panel; NIMH Research Education Applications (R25). E:\FR\FM\15SEN1.SGM 15SEN1

Agencies

[Federal Register Volume 85, Number 179 (Tuesday, September 15, 2020)]
[Notices]
[Page 57224]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-20297]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meetings

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of meetings of the President's Cancer 
Panel.
    The meetings will be held as virtual meetings and are open to the 
public. Individuals who plan to view the virtual meetings and need 
special assistance or other reasonable accommodations to view the 
meetings should notify the Contact Person listed below in advance of 
the meetings. The meetings can be accessed by clicking on the following 
link: https://nci.rev.vbrick.com/#/webcasts/presidentscancerpanel.

    Name of Committee: President's Cancer Panel.
    Date: October 26, 2020.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: Improving Resilience and Equity in Cancer Screening: 
Lessons from COVID-19 and Beyond (Day 1--Lung Cancer).
    Place: National Cancer Institute, 31 Center Drive, Building 31, 
Room 11A48, Rockville, MD 20850 (Virtual Meeting).
    Access to Meeting: https://nci.rev.vbrick.com/#/webcasts/presidentscancerpanel.
    Contact Person: Maureen R. Johnson, Ph.D., Executive Secretary, 
President's Cancer Panel, Special Assistant to the Director, 
National Cancer Institute, NIH, 31 Center Drive, Room 11A48 MSC 
2590, Bethesda, MD 20892, 240-781-3327, [email protected].

    Name of Committee: President's Cancer Panel.
    Date: October 28, 2020.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: Improving Resilience and Equity in Cancer Screening: 
Lessons from COVID-19 and Beyond (Day 2--Lung Cancer).
    Place: National Cancer Institute, 31 Center Drive, Building 31, 
Room 11A48, Bethesda, MD 20892 (Virtual Meeting).
    Access to Meeting: https://nci.rev.vbrick.com/#/webcasts/presidentscancerpanel.
    Contact Person: Maureen R. Johnson, Ph.D., Executive Secretary, 
President's Cancer Panel, Special Assistant to the Director, 
National Cancer Institute, NIH, 31 Center Drive, Room 11A48 MSC 
2590, Bethesda, MD 20892, 240-781-3327, [email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: http://deainfo.nci.nih.gov/advisory/pcp/index.htm, where 
agendas and any additional information for the meetings will be 
posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: September 9, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-20297 Filed 9-14-20; 8:45 am]
BILLING CODE 4140-01-P